Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 52Lung Neoplasms 11Breast Neoplasms 11Head and Neck Neoplasms 8Neoplasms 5Neoplasm Metastasis 4NSCLC 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Colorectal Neoplasms 3Carcinoma 3Brain Neoplasms 3Respiratory Tract Diseases 2Neoplasms, Squamous Cell 2Carcinoma, Squamous Cell 2Adenocarcinoma of Lung 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1Small Cell Lung Carcinoma 1Respiratory Tract Neoplasms 1Pancreatic Neoplasms 1Non-Metastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma 1Lung Diseases 1

Interventions

Carboplatin 7aflutinib 5Pemetrexed 5osimertinib 4Gefitinib 4HM781-36B 3rezivertinib 2pembrolizumab 2Paclitaxel 2HMPL-013 2Docetaxel 2Cisplatin 2Albumin-Bound Paclitaxel 2tipifarnib 1sulindac sulfone 1spartalizumab 1icotinib 1aumolertinib 1apatinib 1Vinorelbine 1Taxes 1Gemcitabine 1Erlotinib Hydrochloride 1Clinical Trials, Phase I as Topic 1Cetuximab 1CP protocol 1Bortezomib 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × NSCLC × Gefitinib × Clear all
NCT03866499 2024-08-07

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

Beta Pharma, Inc.

Phase 3 Active not recruiting
369 enrolled
Thoracic

NSCLC

NCT04390984 2021-01-11

Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown
22 enrolled
Thoracic

NSCLC

NCT02976116 2019-11-15

A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer

Hutchmed

Phase 2 Completed
50 enrolled
Thoracic

NSCLC

NCT00259064 2016-06-02

INSTEP

AstraZeneca

Phase 2/3 Completed
216 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡